Studies related to Symptoms of Vitiligo and Ginkgo biloba

Ginkgo Biloba For The Treatment Of Vitilgo Vulgaris: An Open Label Pilot Clinical Trial

Effect Decrease
Trial Design Non-controlled trial
Trial Length 1-6 months
Number of Subjects 11
Sex Both Genders
Age Range 13-17, 18-29, 30-44
Notes for this study:
Symptoms of vitilgo vulgaris appear to be reduced with 12 weeks supplementation of 120mg EGb-761 daily, associated with a 15% skin repigmentation rate and 0.4% reduced lesion size.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.